Build Your Comparison

Side-by-side financial analysis
TRNS logo
TRNS
NVST logo
NVST
JPM logo
JPM
DHR logo
DHR
BAC logo
BAC
Try popular comparisons:

Stock Comparison

TRNS vs NVST vs JPM vs DHR vs BAC

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
TRNS
Transcat, Inc.

Industrial - Distribution

IndustrialsNASDAQ • US
Market Cap$852M
5Y Perf.+252.9%
NVST
Envista Holdings Corp

Medical - Equipment & Services

HealthcareNYSE • US
Market Cap$4.01B
5Y Perf.+16.6%
JPM
JPMorgan Chase & Co.

Banks - Diversified

Financial ServicesNYSE • US
Market Cap$896.00B
5Y Perf.+241.0%
DHR
Danaher Corporation

Medical - Diagnostics & Research

HealthcareNYSE • US
Market Cap$127.47B
5Y Perf.+14.9%
BAC
Bank of America Corporation

Banks - Diversified

Financial ServicesNYSE • US
Market Cap$422.78B
5Y Perf.+135.9%

TRNS vs NVST vs JPM vs DHR vs BAC — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
TRNS logoTRNS
NVST logoNVST
JPM logoJPM
DHR logoDHR
BAC logoBAC
IndustryIndustrial - DistributionMedical - Equipment & ServicesBanks - DiversifiedMedical - Diagnostics & ResearchBanks - Diversified
Market Cap$852M$4.01B$896.00B$127.47B$422.78B
Revenue (TTM)$333M$2.81B$280.33B$24.78B$191.57B
Net Income (TTM)$7M$68M$57.05B$3.69B$30.51B
Gross Margin32.6%55.1%60.0%60.7%56.1%
Operating Margin4.1%9.0%25.9%21.0%19.7%
Forward P/E51.9x17.2x14.4x21.3x12.6x
Total Debt$129M$1.71B$942.38B$18.42B$365.90B
Cash & Equiv.$5M$1.21B$343.34B$4.62B$231.84B

TRNS vs NVST vs JPM vs DHR vs BACLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

TRNS
NVST
JPM
DHR
BAC
StockJun 20Jun 26Return
Transcat, Inc. (TRNS)100352.9+252.9%
Envista Holdings Co… (NVST)100116.6+16.6%
JPMorgan Chase & Co. (JPM)100341.0+241.0%
Danaher Corporation (DHR)100114.9+14.9%
Bank of America Cor… (BAC)100235.9+135.9%

Price return only. Dividends and distributions are not included.

Quick Verdict: TRNS vs NVST vs JPM vs DHR vs BAC

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: JPM and DHR are tied at the top with 2 categories each (5-stock set) — the right choice depends on your priorities. Danaher Corporation is the stronger pick specifically for capital preservation and lower volatility and operational efficiency and capital deployment. TRNS, NVST, and BAC also each lead in at least one category. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
TRNS
Transcat, Inc.
The Long-Run Compounder

TRNS ranks third and is worth considering specifically for long-term compounding.

  • 7.7% 10Y total return vs JPM's 465.8%
  • 19.2% revenue growth vs BAC's -0.5%
Best for: long-term compounding
NVST
Envista Holdings Corp
The Growth Play

NVST is the clearest fit if your priority is growth exposure.

  • Rev growth 8.3%, EPS growth 104.3%, 3Y rev CAGR 1.9%
  • +30.4% vs DHR's -11.5%
Best for: growth exposure
JPM
JPMorgan Chase & Co.
The Banking Pick

JPM has the current edge in this matchup, primarily because of its strength in valuation efficiency and bank quality.

  • PEG 0.81 vs DHR's 35.21
  • NIM 2.2% vs BAC's 1.8%
  • Lower P/E (14.4x vs 21.3x), PEG 0.81 vs 35.21
  • 20.4% margin vs TRNS's 2.0%
Best for: valuation efficiency and bank quality
DHR
Danaher Corporation
The Defensive Pick

DHR is the #2 pick in this set and the best alternative if sleep-well-at-night is your priority.

  • Lower volatility, beta 0.70, Low D/E 35.1%, current ratio 1.87x
  • Beta 0.70 vs NVST's 1.45, lower leverage
  • 4.5% ROA vs BAC's 0.9%, ROIC 5.9% vs 3.5%
Best for: sleep-well-at-night
BAC
Bank of America Corporation
The Banking Pick

BAC is the clearest fit if your priority is income & stability and defensive.

  • Dividend streak 12 yrs, beta 0.86, yield 2.3%
  • Beta 0.86, yield 2.3%, current ratio 0.42x
  • 2.3% yield, 12-year raise streak, vs JPM's 1.9%, (2 stocks pay no dividend)
Best for: income & stability and defensive
See the full category breakdown
CategoryWinnerWhy
GrowthTRNS logoTRNS19.2% revenue growth vs BAC's -0.5%
ValueJPM logoJPMLower P/E (14.4x vs 21.3x), PEG 0.81 vs 35.21
Quality / MarginsJPM logoJPM20.4% margin vs TRNS's 2.0%
Stability / SafetyDHR logoDHRBeta 0.70 vs NVST's 1.45, lower leverage
DividendsBAC logoBAC2.3% yield, 12-year raise streak, vs JPM's 1.9%, (2 stocks pay no dividend)
Momentum (1Y)NVST logoNVST+30.4% vs DHR's -11.5%
Efficiency (ROA)DHR logoDHR4.5% ROA vs BAC's 0.9%, ROIC 5.9% vs 3.5%

TRNS vs NVST vs JPM vs DHR vs BAC — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

Discover the Biotech & Healthcare Stocks Theme

These companies are key players in the Biotech & Healthcare Stocks ecosystem. See how they stack up against the rest of the sector.

Explore Theme
TRNSTranscat, Inc.
FY 2025
Service
65.4%$217M
Distribution Service
34.6%$115M
NVSTEnvista Holdings Corp
FY 2024
Specialty Products and Technologies
64.4%$1.6B
Equipment and Consumables
35.6%$894M
JPMJPMorgan Chase & Co.
FY 2025
Commercial And Investment Bank
43.0%$78.5B
Consumer & Community Banking
41.7%$76.0B
Asset and Wealth Management Segment
13.2%$24.1B
Segment Reporting, Reconciling Item, Corporate Nonsegment
3.9%$7.0B
Segment Reconciling Items
-1.7%$-3,134,000,000
DHRDanaher Corporation
FY 2025
Revenue from Contract with Customer, Measurement, Recurring
81.9%$20.1B
Revenue from Contract with Customer, Measurement, Nonrecurring
18.1%$4.4B
BACBank of America Corporation
FY 2024
Loans and Leases
32.2%$62.0B
other interest income
14.7%$28.3B
Debt securities
13.5%$26.0B
Federal funds sold and securities borrowed or purchased under agreements to resell
10.3%$19.9B
Investment And Brokerage Services
9.2%$17.8B
Market making and similar activities
6.7%$13.0B
Trading account assets
5.4%$10.4B
Other (4)
7.8%$15.1B

TRNS vs NVST vs JPM vs DHR vs BAC — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLJPMLAGGINGBAC

Income & Cash Flow (Last 12 Months)

JPM leads this category, winning 3 of 6 comparable metrics.

JPM is the larger business by revenue, generating $280.3B annually — 842.9x TRNS's $333M. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to TRNS's 2.0%. On growth, TRNS holds the edge at +15.8% YoY revenue growth, suggesting stronger near-term business momentum.

MetricTRNS logoTRNSTranscat, Inc.NVST logoNVSTEnvista Holdings …JPM logoJPMJPMorgan Chase & …DHR logoDHRDanaher Corporati…BAC logoBACBank of America C…
RevenueTrailing 12 months$333M$2.8B$280.3B$24.8B$191.6B
EBITDAEarnings before interest/tax$40M$342M$81.4B$7.2B$40.0B
Net IncomeAfter-tax profit$7M$68M$57.0B$3.7B$30.5B
Free Cash FlowCash after capex$20M$220M$100.9B$5.3B$12.6B
Gross MarginGross profit ÷ Revenue+32.6%+55.1%+60.0%+60.7%+56.1%
Operating MarginEBIT ÷ Revenue+4.1%+9.0%+25.9%+21.0%+19.7%
Net MarginNet income ÷ Revenue+2.0%+2.4%+20.4%+14.9%+15.9%
FCF MarginFCF ÷ Revenue+5.9%+7.8%+36.0%+21.4%+6.6%
Rev. Growth (YoY)Latest quarter vs prior year+15.8%+14.4%+3.7%
EPS Growth (YoY)Latest quarter vs prior year-56.3%+130.0%+16.0%+9.8%+18.3%
JPM leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

NVST leads this category, winning 3 of 7 comparable metrics.

At 14.7x trailing earnings, BAC trades at a 91% valuation discount to TRNS's 160.1x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 0.90x vs NVST's 58.84x — a lower PEG means you pay less per unit of expected earnings growth.

MetricTRNS logoTRNSTranscat, Inc.NVST logoNVSTEnvista Holdings …JPM logoJPMJPMorgan Chase & …DHR logoDHRDanaher Corporati…BAC logoBACBank of America C…
Market CapShares × price$852M$4.0B$896.0B$127.5B$422.8B
Enterprise ValueMkt cap + debt − cash$976M$4.5B$1.50T$141.3B$556.8B
Trailing P/EPrice ÷ TTM EPS160.11x87.86x16.00x35.73x14.66x
Forward P/EPrice ÷ next-FY EPS est.51.85x17.18x14.40x21.34x12.56x
PEG RatioP/E ÷ EPS growth rate58.84x0.90x35.21x0.95x
EV / EBITDAEnterprise value multiple24.76x13.19x18.36x18.63x13.92x
Price / SalesMarket cap ÷ Revenue2.57x1.47x3.20x5.19x2.21x
Price / BookPrice ÷ Book value/share2.83x1.34x2.47x2.44x1.39x
Price / FCFMarket cap ÷ FCF43.60x17.40x8.88x24.23x33.52x
NVST leads this category, winning 3 of 7 comparable metrics.

Profitability & Efficiency

DHR leads this category, winning 5 of 9 comparable metrics.

JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $2 for NVST. DHR carries lower financial leverage with a 0.35x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), NVST scores 7/9 vs JPM's 5/9, reflecting strong financial health.

MetricTRNS logoTRNSTranscat, Inc.NVST logoNVSTEnvista Holdings …JPM logoJPMJPMorgan Chase & …DHR logoDHRDanaher Corporati…BAC logoBACBank of America C…
ROE (TTM)Return on equity+2.2%+2.2%+15.9%+7.1%+10.1%
ROA (TTM)Return on assets+1.4%+1.2%+1.3%+4.5%+0.9%
ROICReturn on invested capital+2.6%+4.8%+4.5%+5.9%+3.5%
ROCEReturn on capital employed+3.3%+4.9%+8.9%+7.0%+4.5%
Piotroski ScoreFundamental quality 0–957577
Debt / EquityFinancial leverage0.43x0.55x2.60x0.35x1.21x
Net DebtTotal debt minus cash$124M$496M$599.0B$13.8B$134.1B
Cash & Equiv.Liquid assets$5M$1.2B$343.3B$4.6B$231.8B
Total DebtShort + long-term debt$129M$1.7B$942.4B$18.4B$365.9B
Interest CoverageEBIT ÷ Interest expense2.81x12.76x0.74x18.13x0.48x
DHR leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

JPM leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in JPM five years ago would be worth $21,820 today (with dividends reinvested), compared to $5,655 for NVST. Over the past 12 months, NVST leads with a +30.4% total return vs DHR's -11.5%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.6% vs NVST's -8.3% — a key indicator of consistent wealth creation.

MetricTRNS logoTRNSTranscat, Inc.NVST logoNVSTEnvista Holdings …JPM logoJPMJPMorgan Chase & …DHR logoDHRDanaher Corporati…BAC logoBACBank of America C…
YTD ReturnYear-to-date+59.7%+13.4%-0.5%-21.7%+1.1%
1-Year ReturnPast 12 months+17.9%+30.4%+21.8%-11.5%+28.1%
3-Year ReturnCumulative with dividends-1.0%-22.9%+138.2%-13.0%+103.0%
5-Year ReturnCumulative with dividends+66.3%-43.4%+118.2%-15.5%+47.1%
10-Year ReturnCumulative with dividends+769.1%-12.0%+465.8%+222.6%+368.2%
CAGR (3Y)Annualised 3-year return-0.3%-8.3%+33.6%-4.5%+26.6%
JPM leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

Evenly matched — DHR and BAC each lead in 1 of 2 comparable metrics.

DHR is the less volatile stock with a 0.70 beta — it tends to amplify market swings less than NVST's 1.45 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BAC currently trades 97.3% from its 52-week high vs DHR's 74.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricTRNS logoTRNSTranscat, Inc.NVST logoNVSTEnvista Holdings …JPM logoJPMJPMorgan Chase & …DHR logoDHRDanaher Corporati…BAC logoBACBank of America C…
Beta (5Y)Sensitivity to S&P 5001.35x1.45x0.94x0.70x0.86x
52-Week HighHighest price in past year$94.76$30.42$337.25$242.80$57.55
52-Week LowLowest price in past year$50.23$18.25$262.71$160.93$43.66
% of 52W HighCurrent price vs 52-week peak+96.3%+80.9%+95.1%+74.2%+97.3%
RSI (14)Momentum oscillator 0–10062.754.159.152.068.3
Avg Volume (50D)Average daily shares traded155K2.8M7.0M4.2M31.7M
Evenly matched — DHR and BAC each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — JPM and BAC each lead in 1 of 2 comparable metrics.

Analyst consensus: TRNS as "Buy", NVST as "Hold", JPM as "Buy", DHR as "Buy", BAC as "Buy". Consensus price targets imply 35.4% upside for TRNS (target: $124) vs 5.9% for JPM (target: $340). For income investors, BAC offers the higher dividend yield at 2.26% vs DHR's 0.69%.

MetricTRNS logoTRNSTranscat, Inc.NVST logoNVSTEnvista Holdings …JPM logoJPMJPMorgan Chase & …DHR logoDHRDanaher Corporati…BAC logoBACBank of America C…
Analyst RatingConsensus buy/hold/sellBuyHoldBuyBuyBuy
Price TargetConsensus 12-month target$123.60$28.33$339.75$231.80$61.13
# AnalystsCovering analysts1019614354
Dividend YieldAnnual dividend ÷ price+1.9%+0.7%+2.3%
Dividend StreakConsecutive years of raises015912
Dividend / ShareAnnual DPS$5.95$1.23$1.27
Buyback YieldShare repurchases ÷ mkt cap+0.1%+4.2%+3.9%+2.4%+5.1%
Evenly matched — JPM and BAC each lead in 1 of 2 comparable metrics.
Key Takeaway

JPM leads in 2 of 6 categories (Income & Cash Flow, Total Returns). NVST leads in 1 (Valuation Metrics). 2 tied.

Best OverallJPMorgan Chase & Co. (JPM)Leads 2 of 6 categories
Loading custom metrics...

TRNS vs NVST vs JPM vs DHR vs BAC: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is TRNS or NVST or JPM or DHR or BAC a better buy right now?

For growth investors, Transcat, Inc.

(TRNS) is the stronger pick with 19. 2% revenue growth year-over-year, versus -0. 5% for Bank of America Corporation (BAC). Bank of America Corporation (BAC) offers the better valuation at 14. 7x trailing P/E (12. 6x forward), making it the more compelling value choice. Analysts rate Transcat, Inc. (TRNS) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — TRNS or NVST or JPM or DHR or BAC?

On trailing P/E, Bank of America Corporation (BAC) is the cheapest at 14.

7x versus Transcat, Inc. at 160. 1x. On forward P/E, Bank of America Corporation is actually cheaper at 12. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 0. 81x versus Danaher Corporation's 35. 21x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — TRNS or NVST or JPM or DHR or BAC?

Over the past 5 years, JPMorgan Chase & Co.

(JPM) delivered a total return of +118. 2%, compared to -43. 4% for Envista Holdings Corp (NVST). Over 10 years, the gap is even starker: TRNS returned +769. 1% versus NVST's -12. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — TRNS or NVST or JPM or DHR or BAC?

By beta (market sensitivity over 5 years), Danaher Corporation (DHR) is the lower-risk stock at 0.

70β versus Envista Holdings Corp's 1. 45β — meaning NVST is approximately 107% more volatile than DHR relative to the S&P 500. On balance sheet safety, Danaher Corporation (DHR) carries a lower debt/equity ratio of 35% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.

05

Which is growing faster — TRNS or NVST or JPM or DHR or BAC?

By revenue growth (latest reported year), Transcat, Inc.

(TRNS) is pulling ahead at 19. 2% versus -0. 5% for Bank of America Corporation (BAC). On earnings-per-share growth, the picture is similar: Envista Holdings Corp grew EPS 104. 3% year-over-year, compared to -63. 7% for Transcat, Inc.. Over a 3-year CAGR, TRNS leads at 12. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — TRNS or NVST or JPM or DHR or BAC?

JPMorgan Chase & Co.

(JPM) is the more profitable company, earning 20. 4% net margin versus 1. 6% for Transcat, Inc. — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus 4. 0% for TRNS. At the gross margin level — before operating expenses — DHR leads at 60. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is TRNS or NVST or JPM or DHR or BAC more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 0. 81x versus Danaher Corporation's 35. 21x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Bank of America Corporation (BAC) trades at 12. 6x forward P/E versus 51. 9x for Transcat, Inc. — 39. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TRNS: 35. 4% to $123. 60.

08

Which pays a better dividend — TRNS or NVST or JPM or DHR or BAC?

In this comparison, BAC (2.

3% yield), JPM (1. 9% yield), DHR (0. 7% yield) pay a dividend. TRNS, NVST do not pay a meaningful dividend and should not be held primarily for income.

09

Is TRNS or NVST or JPM or DHR or BAC better for a retirement portfolio?

For long-horizon retirement investors, Danaher Corporation (DHR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

70), 0. 7% yield, +222. 6% 10Y return). Both have compounded well over 10 years (DHR: +222. 6%, NVST: -12. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between TRNS and NVST and JPM and DHR and BAC?

These companies operate in different sectors (TRNS (Industrials) and NVST (Healthcare) and JPM (Financial Services) and DHR (Healthcare) and BAC (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: TRNS is a small-cap high-growth stock; NVST is a small-cap quality compounder stock; JPM is a large-cap deep-value stock; DHR is a mid-cap quality compounder stock; BAC is a large-cap deep-value stock. JPM, DHR, BAC pay a dividend while TRNS, NVST do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.